The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Campral EC 333mg Gastro-resistant tablets

Merck Serono (Ireland) LimitedPA2286/007/001

Main Information

Trade NameCampral EC 333mg Gastro-resistant tablets
Active SubstancesAcamprosate calcium
Dosage FormGastro-resistant tablet
Licence HolderMerck Serono (Ireland) Limited
Licence NumberPA2286/007/001

Group Information

ATC CodeN07BB Drugs used in alcohol dependence
N07BB03 acamprosate


License statusAuthorised
Licence Issued16/02/1996
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back